A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management
1995
Safety and Tolerability of Levocabastine Eye Drops and Nasal Spray
Sample size: 3386
publication
Evidence: moderate
Author Information
Author(s): Peter H. Howarth
Primary Institution: University of Medicine, Southampton General Hospital
Hypothesis
Levocabastine is a well-tolerated and effective treatment for allergic rhinoconjunctivitis.
Conclusion
Levocabastine eye drops and nasal spray are effective and well tolerated, with minimal adverse effects.
Supporting Evidence
- Levocabastine is 15,000 times more potent than chlorpheniramine.
- Local irritation is the most common side effect, occurring in 14% of patients using eye drops.
- Adverse effects are comparable to those of sodium cromoglycate and placebo.
- Levocabastine has minimal systemic absorption, reducing the risk of systemic side effects.
- Clinical trials show no significant effects on cardiovascular or cognitive functions.
Takeaway
Levocabastine is a medicine that helps with allergies and is safe to use, causing very few side effects.
Methodology
The review summarizes data from clinical trials evaluating the tolerability and safety of levocabastine.
Limitations
The review may not cover all potential adverse effects or long-term safety data.
Participant Demographics
Included both adults and children aged 6 to 15 years.
Want to read the original?
Access the complete publication on the publisher's website